Bizarre Patents
Mouthguard made at least partially from an edible candy
A mouthguard includes a U-shaped upper bite plate which removably fits over upper teeth of a person, with the entire upper bite plate being made from a soft, deformable and edible gummi candy.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6312706 | Prepolymers useful in biomedical devices A novel polyurethane based prepolymer useful in biomedical devices which provides high oxygen permeability and superior physical properties.... | 11/06/2001 |
| 6299895 | Device and method for treating ophthalmic diseases A method and device for delivering a biologically active molecule to the eye, either intraocularly or periocularly, and method and device for treating ophthalmic disorders in a patient suffering therefrom.... | 10/09/2001 |
| 6274160 | Methods of use of histamine H2 agonists in treating dry eye A topical ophthalmic composition for the treatment of dry eye in humans, comprising one or more histamine H2 agonists, is disclosed.... | 08/14/2001 |
| 6264941 | Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules This invention provides improved devices and methods for long-term, stable expression of a biologically active molecule using a biocompatible capsule containing genetically engineered cells for the effective delivery of biologically active molecules to ef... | 07/24/2001 |
| 6264935 | Ophthalmic composition containing a carbonic anhydrase inhibitor and xanthan gum The present invention relates to ophthalmic compositions for the treatment of ocular hypertension and glaucoma, comprising a hypotonic solution of 0.1 to 0.2% (w/w) of xanthan gum and 0.5 to 5% (w/w) of a topical carbonic anhydrase inhibitor or an ophthal... | 07/24/2001 |
| 6264971 | Ocular insert A flexible ocular insert device adapted for the controlled sustained release of a drug upon insertion into the upper or lower fornix of the eye. The device comprises an elongate body of a polymeric material including two end portions, wherein the body con... | 07/24/2001 |
| 6261546 | Methods and compositions for stabilizing acetylcholine compositions A pharmaceutical product which includes two-chambers, one having a buffered diluent and the other having acetylcholine. Upon mixing the chamber contents, a buffered efficacious acetylcholine product is prepared for post-surgical ophthlamic injection. Anot... | 07/17/2001 |
| 6258856 | Method for preventing or controlling cataract A method for preventing or treating pathological changes which occur in association with cataract formation in the mammalian eye by protecting lens cells against the cataractogenic effects of transforming growth factor-ଲ (TGFଲ). Estrogen or an... | 07/10/2001 |
| 6248363 | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered. In one embodiment, the solid pharmaceutical composition includes a ... | 06/19/2001 |
| 6242198 | Methods of treatment of eye trauma and disorders Methods are provided for treatment of eye disorders and injury, including methods for treatment of reduced flow of blood or other nutrients to retinal tissue and/or optic nerve, methods for treatment of retinal ischemia and trauma and methods for treatmen... | 06/05/2001 |
| 6231889 | Unit dosage forms for the treatment of herpes simplex The components of this invention are chosen because of their complementarity for the prevention or treatment of diseases caused by the herpes simplex virus. L-Lysine favorably increases the physiologic immunomodulation necessary for defense against this v... | 05/15/2001 |
| 6221401 | Bilayer structure which encapsulates multiple containment units and uses thereof The present invention provides a bilayer structure for encapsulating multiple containment units. These containment units can attach or contain therapeutic or diagnostic agents that can be released through the bilayer structure. A suitable example of such ... | 04/24/2001 |
| 6217895 | Method for treating and/or preventing retinal diseases with sustained release corticosteroids The present invention relates to a method for administering a corticosteroid to a posterior segment of an eye. In the method, a sustained release device is implanted to deliver the corticosteroid to the eye. The aqueous corticosteroid concentration remain... | 04/17/2001 |
| 6218373 | Formulations containing hyaluronic acid A method of treating a disease of condition administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage comprising a therapeutically effective amount of a drug to treat said disease or con... | 04/17/2001 |
| 6217896 | Conjunctival inserts for topical delivery of medication or lubrication The present invention provides an improved conjunctival insert for topical delivery of medication or lubrication into the conjunctival spaces and upon the ocular surface of human eye. Specifically, three physical designs are provided, differing by size, n... | 04/17/2001 |
| 6210706 | S (+) Desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and conditions... | 04/03/2001 |
| 6207172 | Composition for the delivery of a pharmaceutical agent to a patient The present invention relates to a composition for the delivery of a pharmaceutical agent to a patient that comprises polyethylene glycol, an aqueous solution containing polyvinylpyrrolidone, and a pharmaceutical agent. The invention also relates to metho... | 03/27/2001 |
| 6193957 | Pharmaceutical compositions for treating late phase allergic reactions and inflammatory diseases A method of treating a mammalian patient suffering from or prone to a condition characterized by late phase allergic reactions, airway hyperresponsiveness or inflammatory reactions, e.g., asthma, allergic rhinitis, allergic dermatitis, allergic conjunctiv... | 02/27/2001 |
| 6180687 | In vivo polymerizable ophthalmic compositions and methods of using In vivo polymerizable intraocular lens compositions which comprise substituted fluoroalkyl or perfluoroalkyl monomers having anionic, cationic, and/or nonionic surface active functionality in the unsaturated fluorophobic ends. The compositions are prefera... | 01/30/2001 |
| 6165490 | Biological material, method of preparing such materials, uses thereof and products made therefrom A biological material is prepared for use in ophthalmology by steps of providing animal pericardium, subjecting the animal pericardium to multiple steps of freezing and thawing in a salt solution and incubating the animal pericardium in a solution of ammo... | 12/26/2000 |
| 6153217 | Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents A process for producing a small-sized, lipid-based cochleate is described. Cochleates are derived from liposomes which are suspended in an aqueous two-phase polymer solution, enabling the differential partitioning of polar molecule based-structure by phas... | 11/28/2000 |
| 6149931 | Methods and pharmaceutical compositions for the closure of retinal breaks Described are compositions, methods, and articles of manufacture for the closure of retinal breaks with a non-toxic polymer. Transformation to a gel-like coat is achieved by photochemical reactivity, chemical reactivity, and by physicochemical response.... | 11/21/2000 |
| 6143315 | Biochemical contact lens for treating injured corneal tissue Methods for treating injured corneal tissue are described. The methods include contacting injured corneal tissue with a contact lens which includes an amniotic composition such that scarring of the injured corneal tissue is reduced. Methods for conditioni... | 11/07/2000 |
| 6136334 | Medical uses of in situ formed gels Balanced pH, hyperosmotic, hypoosmotic, or isoosmotic gels are ideal vehicles for drug delivery. They are especially suited for topical body cavity or injection application of drugs or diagnostic agents; for drug or diagnostic agent delivery to the eye of... | 10/24/2000 |
| 6136793 | Formulations containing hyaluronic acid A method of treating a disease or condition comprising administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage comprising a therapeutically effective amount of a drug to treat said dis... | 10/24/2000 |
| 6132751 | O/W emulsion composition for eye drops An O/W emulsion composition for eye drops comprises a drug selected from the group consisting of fluorometholone, clobetasone butyrate and clobetasol propionate; a phospholipid; liquid paraffine; and water. The O/W emulsion composition is excellent in sol... | 10/17/2000 |
| 6132755 | Transcorneal drug-release system The invention refers to a transcorneal system for the actively controlled transcorneal delivery of a medicament into a subject comprising an active substance reservoir and a device provided with a plurality of micro-pins or micro-blades adapted in use to ... | 10/17/2000 |
| 6126957 | Method of treating disorders of the eye The present invention relates, in general, to methods of treating disorders of the eye, and, in particular, to methods of preventing or treating elevated eye pressure and glaucoma. The invention further relates to compounds and compositions suitable for u... | 10/03/2000 |
| 6120484 | Otological implant for delivery of medicament and method of using same The present invention is directed to an otological implant for delivery of medicament and a method of using the implant. The implant includes a wick inserted through an aperture in a membrane. One end of the wick is in contact with the treatment site and ... | 09/19/2000 |
| 6121329 | Topical administration of 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol An external preparation for topical administration which aims at inhibiting rejection reactions at organ or bone marrow transplantation or treating autoimmune diseases or allergic diseases and contains as the active ingredient 2-amino-2-(2-(4-octylphenyl)... | 09/19/2000 |
| 6117445 | Methods for the prevention and treatment of fibrosis and sclerosis Methods of treating or preventing fibrosis and sclerosis by the administration of compositions containing A1 adenosine receptor antagonists and/or P2X purinoceptor antagonists, or combinations thereof.... | 09/12/2000 |
| 6110485 | Sterile bioerodible implant device with a retinoid for improved biocompatability An implantable device is provided which incorporates a retinoid for improving the biocompatability of the device in tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a per... | 08/29/2000 |
| 6074661 | Sterile bioerodible occular implant device with a retinoid for improved biocompatability An implantable device is provided which incorporates a retinoid for improving the biocompatability of the device in eye tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a... | 06/13/2000 |
| 6068851 | Formulation for use in the prevention of pathogen induced diseases including HIV and HSV This invention relates to formulations comprising film-forming components capable of forming per se a physical barrier to pathogens. Thermoreversible gels such as poloxamers are particularly preferred for that use. The film-forming formulations may furthe... | 05/30/2000 |
| 6063396 | Methods and compositions for the modulation of cell proliferation and wound healing Implants which are capable of sustained release of a cell proliferation modulating agent, together with methods for their preparation and use, are provided. The proliferation modulating agent is associated either covalently or non-covalently with the mate... | 05/16/2000 |
| 6054485 | Eye treatments using synthetic thyroid hormone compositions The present invention involves the discovery that synthetic thyroid hormones can be used as compositions to reduce intraocular pressure in vivo. Methods of screening synthetic thyroid hormones for effect on intraocular pressure, aqueous pressure, hydrauli... | 04/25/2000 |
| 6027745 | Process for producing controlled drug-release contact lens, and controlled drug-release contact lens thereby produced A process for producing a controlled drug-release contact lens, containing a first member which forms a front fact of the lens and a second member which forms a rear face of the lens, the first and second members defining a space in the contact lens, whic... | 02/22/2000 |
| 6022561 | Bilayers preparations A galactolipid material from wheat, produced by extraction of crushed wheat grains and subsequent chromatography of the extracted material, and having a content of DGDG of 51.5%, was mixed with the polar solvents, water and glycerol in order to test the s... | 02/08/2000 |
| 6017900 | Topical composition containing hyaluronic acid and nsaids A pharmaceutical composition comprising a plurality of effective non-toxic dosage amounts of a composition for topical administration to the site of pathology or trauma of skin or exposed tissue of a human patient in need of treatment suffering from a dis... | 01/25/2000 |
| 6017554 | Composition for treating abnormal conditions of the epithelium of bodily orifices A stable solution cream, salve, or spray composition containing activated stabilized chlorine dioxide and phosphates, such as disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, and sodium monofluorophosphate, is disclosed for t... | 01/25/2000 |
